课题基金 / 基金详情

National HIV Behavioral Surveillance System

National HIV Behavioral Surveillance System
国家艾滋病毒行为监测系统
批准号:
8400862
负责人:
TOM JAENICKE
金额:
$44.89万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-01-01 至 2015-12-31

项目摘要

项目成果

TOM JAENICKE的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结/摘要 美国疾病控制与预防中心(CDC)目前正在进行全国艾滋病毒 美国21个大都市统计区(MSA)的行为监测(NHBS),包括 西雅图MSA。我们建议从2011年到2015年继续在西雅图MSA实施NHBS。的 西雅图MSA的NHBS的目标是为当地的HIV预防资源提供相关数据 分配和预防方案评估。为了实现这一目标,我们建议 与CDC合作,继续维护和评估行为监测系统 与男男性行为者感染艾滋病毒有关的合并感染,注射 吸毒者(IDU)和风险增加的异性恋者(HET)。具体来说,我们将 形成性研究和基于社区的调查以及艾滋病毒检测。我们将进行 每年进行一次调查,评估艾滋病毒危险行为、艾滋病毒预防服务的获得和利用情况, 西雅图地区MSM(2011年和2014年)、IDU(2012年和2015年)和HET的艾滋病毒感染率 (2014年)。我们将与西雅图地区的社区组织、公共卫生 部门的同事,华盛顿大学的研究人员在定性和 采用定量方法进行NHBS并评估和传播结果。我们会委聘 基于场地的时空抽样(VBS)和响应者驱动抽样(RDS), 对男男性行为者和注射吸毒者各周期500名合格参与者和HET 450名合格参与者进行调查 周期我们将为所有三个国家的NHBS参与者提供自愿的艾滋病毒咨询和检测。 评估艾滋病毒血清阳性率。我们将对NHBS系统进行评估 包括抽样策略和数据收集方法,以确保系统满足其 目标,并就如何提高 NHBS在当地和国家。我们将合作开发和实施 当地预防调查问题与西雅图地区社区为基础的组织, 由CDC直接资助或由州或地方通过社区规划资助 过程我们将为MMWR报告等国家数据收集成果做出贡献 和其他出版物,并提供数据传播计划, 国家监测报告工作。最后,我们将实施丙型肝炎咨询, 在MSM和IDU周期中进行检测,以评估丙型肝炎血清阳性率。西雅图地区 NHBS系统将继续以西雅图公共卫生艾滋病毒/性病方案为基础, 国王郡
英文摘要
Project Summary/Abstract The Centers for Disease Control and Prevention (CDC) currently conducts National HIV Behavioral Surveillance (NHBS) in 21 metropolitan statistical areas (MSA) in the U.S., including the Seattle MSA. We propose to continue NHBS in the Seattle MSA from 2011 to 2015. The goal of NHBS in the Seattle MSA is to provide relevant data for local HIV prevention resource allocation and prevention program evaluation. To accomplish this goal, we propose to collaborate with CDC to continue maintaining and evaluating a surveillance system of behaviors and co-infections related to HIV acquisition in men who have sex with men (MSM), injection drug users (IDU), and heterosexuals at increased risk (HET). Specifically, we will conduct formative research and community-based surveys and HIV testing each year. We will conduct a survey each year to assess HIV risk behaviors, HIV prevention services access and utilization, and HIV prevalence among Seattle-area MSM (2011 and 2014), IDU (2012 and 2015) and HET (2014). We will collaborate with Seattle area community-based organizations, public health department colleagues, University of Washington researchers with expertise in qualitative and quantitative methods to conduct NHBS and evaluate and disseminate results. We will employ venue-based time-space sampling (VBS) and respondent-driven sampling (RDS) and complete surveys with 500 eligible participants in each of the MSM and IDU cycles and 450 in the HET cycle. We will provide voluntary HIV counseling and testing to NHBS participants in all three cycles to assess HIV seroprevalence. We will conduct evaluations of the NHBS system including sampling strategies, and data collection methods to ensure that the system meets its goals, and provide recommendations for improving the quality, efficiency and usefulness of NHBS both locally and nationally. We will collaborate on development and implementation of local prevention survey questions with Seattle area community-based organizations that are directly funded by CDC or funded by state or local funding through the community planning process. We will contribute to the national data collections outcomes such as MMWR reports and other publications, and provide a data dissemination plan that will contribute to local and national surveillance reporting efforts. Finally, we will implement hepatitis C counseling and testing in the MSM and IDU cycles to assess hepatitis C seroprevalence. The Seattle area NHBS system will continue to be based at the HIV/STD Program of Public Health - Seattle & King County.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
National HIV Surveillance System
National HIV Surveillance System
National HIV Behavioral Surveillance System
National HIV Behavioral Surveillance System
国内基金
海外基金
人类免疫缺陷病毒(HIV)总核酸检测试剂盒
HIV相关肺癌免疫微环境中关键免疫细胞亚群的功能特征与调控机制研究
基于深度测序与SNV 芯片的HIV重复感染与毒株重组机制研究
  • 批准号:
    2026JJ81281
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    徐艳
  • 依托单位:
HIV相关血管早衰的免疫炎症机制及基于循环生物标志物的风险评估模型构建
  • 批准号:
    2026JJ80647
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    关艳丽
  • 依托单位: